Cdkn1a silencing restores myoblast differentiation by inducing selective apoptosis in senescent cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Inhibiting p21, a marker of cellular senescence, selectively eliminates senescent muscle cells and enhances the regenerative capacity of healthy cells, potentially improving muscle health in aging individuals.
Area Of Science
- Muscle Biology
- Cellular Senescence
- Aging Research
Background
- Sarcopenia involves loss of muscle mass and function due to senescent muscle stem cells.
- Cdkn1a (p21) is a marker of cellular senescence, but its role in sarcopenia is unclear.
- Investigating p21 inhibition's effect on senescent myoblasts and muscle regeneration.
Purpose Of The Study
- To investigate the role of Cdkn1a (p21) in aging-induced sarcopenia.
- To determine if p21 inhibition can eliminate senescent myoblasts and restore muscle differentiation capacity.
Main Methods
- Transcriptomic analysis in aged rats to identify sarcopenia-related genes.
- In vitro ceramide-induced senescence model in myoblasts.
- p21 inhibition using siRNA, cell sorting by caspase activity, and Western blotting for myogenesis, atrophy, and apoptosis markers.
Main Results
- Cdkn1a was upregulated in aged rat muscles, linked to mitochondrial dysfunction and senescence.
- p21 inhibition in senescent myoblasts reduced senescence markers and pro-inflammatory cytokines.
- p21 inhibition selectively induced apoptosis in senescent cells and improved myoblast differentiation.
Conclusions
- p21 inhibition acts as a senolytic, clearing senescent cells.
- This process enhances the regenerative potential of healthy myoblasts.
- Targeting p21 may improve muscle regeneration and function in aging.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...